P722 Symptom-based disease trajectories Identify a population of early super-responders in ulcerative colitis achieving complete disease control under targeted therapy

MLA

F Tran, et al. “P722 Symptom-Based Disease Trajectories Identify a Population of Early Super-Responders in Ulcerative Colitis Achieving Complete Disease Control under Targeted Therapy.” Journal of Crohn’s and Colitis, vol. 17, Jan. 2023, pp. i852–54. EBSCOhost, https://doi.org/10.1093/ecco-jcc/jjac190.0852.

APA

F Tran, R Brard, K Flechsenhar, K Aden, P Rosenstiel, I Agueusop, & S Schreiber. (2023). P722 Symptom-based disease trajectories Identify a population of early super-responders in ulcerative colitis achieving complete disease control under targeted therapy. Journal of Crohn’s and Colitis, 17, i852–i854. https://doi.org/10.1093/ecco-jcc/jjac190.0852

Chicago

F Tran, R Brard, K Flechsenhar, K Aden, P Rosenstiel, I Agueusop, and S Schreiber. 2023. “P722 Symptom-Based Disease Trajectories Identify a Population of Early Super-Responders in Ulcerative Colitis Achieving Complete Disease Control under Targeted Therapy.” Journal of Crohn’s and Colitis 17 (January): i852–54. doi:10.1093/ecco-jcc/jjac190.0852.